FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to method of determining state in blood sample. Method of determining state in blood sample including: providing sample of centrifuged blood divided into layers of plasma and erythrocyte mass; providing measuring probe with pump for aspiration and dispensing; introduction of measuring probe in blood sample vertically in container with samples through plasma downwards to distance of several millimeters from bottom of container; pressure measurement between sample and pump during aspiration or dispensing; comparison of measured pressure with reference value; and supply of signal of presence or absence of condition, where condition is error status, and if measured pressure value does not comply with reference value, error signal is given, and where error state occurs as a result of incomplete centrifugation, and where reference value is selected from group consisting of pressure profile, previously selected range of pressures or inclination of preselected pressure profile section.
EFFECT: method described above is effective for determining state in blood sample.
8 cl, 1 tbl, 6 dwg
Title | Year | Author | Number |
---|---|---|---|
VISCOSITY CALCULATION METHOD | 2011 |
|
RU2562921C2 |
METHOD FOR PRODUCING ERYTHROCYTIC MEMBRANES WITH RESERVED LONG STORAGE MORPHOFUNCTIONAL STATUS | 2010 |
|
RU2436093C1 |
COMPOSITIONS, DIAGNOSTIC TECHNIQUES AND METHOD OF TREATING RENAL DISORDERS IN DOGS | 2010 |
|
RU2546016C2 |
COMPOSITIONS OF TELMISARTAN IN FORM OF NANOPARTICLES, AND METHOD FOR PREPARING THEM | 2010 |
|
RU2526914C2 |
DIAGNOSTIC TECHNIQUE AND KIT FOR DIAGNOSING GLOMERULONEPHITIS IN CAT | 2011 |
|
RU2564122C2 |
SYSTEM FOR ASSESSING SUBSTANCE PREPARATION | 2017 |
|
RU2762936C2 |
NON-INVASIVE LASER NANO-DIAGNOSTIC TECHNIQUE FOR ONCOLOGIC DISEASES | 2013 |
|
RU2542427C2 |
PHARMACEUTICAL COMPOSITION AND METHODS FOR USE | 2017 |
|
RU2719450C1 |
DEVICE FOR RHEOLOGICAL ANALYSIS OF BLOOD | 2014 |
|
RU2570381C1 |
VENLAFAXINE HYDROCHLORIDE SUSTAINED RELEASE COMPOSITION, FILM COVER COMPOSITION, METHOD OF PROVIDING THERAPEUTICALLY ACTIVE VENLAFAXINE CONCENTRATION AND METHOD OF EXCLUDING ZERO AND PEAK CONCENTRATIONS OF MEDICINAL AGENT | 1997 |
|
RU2176912C2 |
Authors
Dates
2017-02-21—Published
2012-02-06—Filed